1. Gender does not affect responses to antithrombotic therapy.
2. 274,433 patients analyzed from 33 trials.
3. Women represented 25% of participants.
4. More intensive therapy reduced myocardial infarction risk by 15%.
5. Major bleeding risk increased by over 40%.
6. Lack of successful randomized trials focusing exclusively on women.
7. Need for better gender diversity in cardiovascular research.
8. Findings relevant across various therapy types and comparisons.

Source: The BMJ